Position in GRFS
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$82,007
-$35,117 QoQ
Shares Held
11,583
-20.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#103
of 164 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GRFS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HighTower Advisors, LLC holds $4,788,622,872 across 16 Drug Manufacturers - General names. GRFS ranks #16 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
9,892,767 | $2,512,466,034 | |
| 2 | LLY |
ELI LILLY & Co
|
436,561 | $523,624,403 | |
| 3 | ABBV |
AbbVie Inc.
|
1,967,343 | $495,062,192 | |
| 4 | MRK |
Merck & Co., Inc.
|
3,679,920 | $472,869,720 | |
| 5 | AMGN |
Amgen Inc
|
816,257 | $295,582,984 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
1,534,627 | $193,884,775 | |
| 7 | AZN |
Astrazeneca PLC
|
455,278 | $86,329,814 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
1,126,721 | $64,921,664 |
All Filings in GRFS
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $82,007 | 11,583 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $117,124 | 14,604 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $133,826 | 14,313 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $200,564 | 20,137 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $169,481 | 18,748 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $121,701 | 17,117 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $132,923 | 17,866 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $123,698 | 13,930 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $78,143 | 12,384 | Shares | Sole | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||